Schietinger A - Search Results

1

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

Schietinger A, Philip M, Krisnawan VE, Chiu EY, Delrow JJ, Basom RS, Lauer P, Brockstedt DG, Knoblaugh SE, Hämmerling GJ, Schell TD, Garbi N, Greenberg PD. Schietinger A, et al. Immunity. 2016 Aug 16;45(2):389-401. doi: 10.1016/j.immuni.2016.07.011. Epub 2016 Aug 9. Immunity. 2016. PMID: 27521269 Free PMC article.

2

Priming of naive T cells inside tumors leads to eradication of established tumors.

Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. Yu P, et al. Among authors: schietinger a. Nat Immunol. 2004 Feb;5(2):141-9. doi: 10.1038/ni1029. Epub 2004 Jan 4. Nat Immunol. 2004. PMID: 14704792 Free article.

3

A mutant chaperone converts a wild-type protein into a tumor-specific antigen.

Schietinger A, Philip M, Yoshida BA, Azadi P, Liu H, Meredith SC, Schreiber H. Schietinger A, et al. Science. 2006 Oct 13;314(5797):304-8. doi: 10.1126/science.1129200. Science. 2006. PMID: 17038624

4

Specificity in cancer immunotherapy.

Schietinger A, Philip M, Schreiber H. Schietinger A, et al. Semin Immunol. 2008 Oct;20(5):276-85. doi: 10.1016/j.smim.2008.07.001. Epub 2008 Aug 5. Semin Immunol. 2008. PMID: 18684640 Free PMC article. Review.

5

Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T cells.

Philip M, Schietinger A, Schreiber H. Philip M, et al. Among authors: schietinger a. Immunology. 2010 Aug;130(4):494-503. doi: 10.1111/j.1365-2567.2010.03258.x. Epub 2010 Mar 16. Immunology. 2010. PMID: 20331471 Free PMC article.

6

Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.

Schietinger A, Philip M, Liu RB, Schreiber K, Schreiber H. Schietinger A, et al. J Exp Med. 2010 Oct 25;207(11):2469-77. doi: 10.1084/jem.20092450. Epub 2010 Oct 4. J Exp Med. 2010. PMID: 20921286 Free PMC article.

7

Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state.

Schietinger A, Delrow JJ, Basom RS, Blattman JN, Greenberg PD. Schietinger A, et al. Science. 2012 Feb 10;335(6069):723-7. doi: 10.1126/science.1214277. Epub 2012 Jan 19. Science. 2012. PMID: 22267581 Free PMC article.

8

Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.

Chou CK, Schietinger A, Liggitt HD, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD. Chou CK, et al. Among authors: schietinger a. J Immunol. 2012 Oct 15;189(8):3936-46. doi: 10.4049/jimmunol.1201415. Epub 2012 Sep 14. J Immunol. 2012. PMID: 22984076 Free PMC article.

9

Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Schietinger A, Greenberg PD. Schietinger A, et al. Trends Immunol. 2014 Feb;35(2):51-60. doi: 10.1016/j.it.2013.10.001. Epub 2013 Nov 6. Trends Immunol. 2014. PMID: 24210163 Free PMC article. Review.

10

Beyond Genomics: Multidimensional Analysis of Cancer Therapy Resistance.

Philip M, Schietinger A. Philip M, et al. Among authors: schietinger a. Trends Immunol. 2015 Nov;36(11):665-667. doi: 10.1016/j.it.2015.09.003. Epub 2015 Oct 1. Trends Immunol. 2015. PMID: 26440701 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters